Image

A Study to Assess Growth in Children With Idiopathic Short Stature

Recruiting
3 - 16 years of age
Both
Phase N/A

Powered by AI

Overview

Study 111-903 will generate baseline growth data in children with ISS by collecting growth measurements and other variables of interest.

Eligibility

Inclusion Criteria:

  1. Participants must be > 2 years old, and ≤ 14 years old (female) or ≤ 16 years old (males) at the time of signing the informed consent.
  2. Participants whose height Z-score is ≤ -2.5 SDs compared to age and sex matched population norms.
  3. Participants are ambulatory and able to stand without assistance (not applicable for children who are < 5 years of age and less than 104 cm in length).
  4. Parent(s) or guardian(s) are willing and able to provide written, signed informed consent.
  5. Participants are willing and able to perform all study procedures.

Exclusion Criteria:

  1. Diagnosis of systemic disease or condition that may cause short stature, eg renal, neoplastic, pulmonary, cardiac, gastrointestinal, immunologic and metabolic disease. Children with such diagnoses can be considered for inclusion if their condition is well controlled, at the discretion of the Medical Monitor.
  2. Known presence of pituitary hormone deficiencies.
  3. Bone age advanced over chronological age by more than 3 years.
  4. Active malignancy, active chemotherapy or radiation therapy for neoplasia.
  5. Have received an investigational product (IP) or investigational medical device for any purpose within 6 months before the Screening visit.
  6. Ongoing treatment for concurrent disease or condition that, in the view of the investigator, would interfere with study participation, for any reason. Participants receiving treatments for attention deficit hyperactivity disorder are not excluded.

Study details

Idiopathic Short Stature

NCT06309979

BioMarin Pharmaceutical

21 March 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.